SOX1 | Jotup

Hybribio Calls for Raising International HPV Awareness

Retrieved on:

Monday, March 4, 2024

International, Hospital, Cervical cancer, Woman, IPVS, SOX1, Methylation, Cancer, Human papillomavirus infection, Wart, Vaccination, World Health Organization, Fluorescence, Organization, HPV, Vagina, WHO, PCR, NMPA

On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.

Key Points:

On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.
In this case, raising HPV awareness, getting timely vaccination and high-quality screening together contribute significantly to the prevention of HPV infection and related diseases.
Hybribio has developed a complete HPV molecular diagnostic solution covering 14 High-risk HPV GenoArray Diagnostic Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, 14 High-risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), 21 HPV GenoArray Diagnostic Kit, 37 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 23 HPV Genotyping Real-time PCR Kit, SOX1 and PAX1 Methylation Real-time PCR Kit.
Raising international HPV awareness is the very first step against cervical cancer.

Hybribio Calls for Raising International HPV Awareness

Retrieved on:

Monday, March 4, 2024

On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.

Key Points:

On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.
In this case, raising HPV awareness, getting timely vaccination and high-quality screening together contribute significantly to the prevention of HPV infection and related diseases.
Hybribio has developed a complete HPV molecular diagnostic solution covering 14 High-risk HPV GenoArray Diagnostic Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, 14 High-risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), 21 HPV GenoArray Diagnostic Kit, 37 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 23 HPV Genotyping Real-time PCR Kit, SOX1 and PAX1 Methylation Real-time PCR Kit.
Raising international HPV awareness is the very first step against cervical cancer.

Hybribio showcased cutting-edge cervical cancer HPV diagnostic solutions at ADLM 2023

Retrieved on:

Monday, July 31, 2023

At the booth No.1482, Hybribio (300639.SZ) featured cervical cancer HPV diagnostic solutions, which include Hybribio 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, 21 HPV GenoArray Diagnostic Kit, 37 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 23 HPV Genotyping Real-time PCR Kit, 14 High-Risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), and SOX1 and PAX1 Methylation Real-time PCR Kit.

Key Points:

At the booth No.1482, Hybribio (300639.SZ) featured cervical cancer HPV diagnostic solutions, which include Hybribio 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, 21 HPV GenoArray Diagnostic Kit, 37 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 23 HPV Genotyping Real-time PCR Kit, 14 High-Risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), and SOX1 and PAX1 Methylation Real-time PCR Kit.
Being the top HPV DNA test manufacturer in China, Hybribio (300639.SZ) not only has the biggest Chinese market share (over 40%) of HPV testing kits but also contributes greatly to the movement of eliminating cervical cancer.
Hybribio (300639.SZ) is going to attend MEDICA 2023 at Dusseldorf, Germany, 13-16 November 2023.
Hybribio is looking forward to meeting you in person at MEDICA 2023, where Hybribio will feature more cutting-edge diagnostics solutions and high-throughput automated instruments.